AMPLIMUNE Trademark

Trademark Overview

On Wednesday, April 29, 2015, a trademark application was filed for AMPLIMUNE with the United States Patent and Trademark Office. The USPTO has given the AMPLIMUNE trademark a serial number of 86613515. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, August 30, 2024. This trademark is owned by Novavive Inc.. The AMPLIMUNE trademark is filed in the Pharmaceutical Products category with the following description:

An immunotherapeutic agent for the treatment of ruminants, namely, for the treatment of neonatal and juvenile diseases; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea in neonates
amplimune

General Information

Serial Number86613515
Word MarkAMPLIMUNE
Filing DateWednesday, April 29, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, August 30, 2024
Registration Number5383140
Registration DateTuesday, January 23, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements

Goods and ServicesAn immunotherapeutic agent for the treatment of ruminants, namely, for the treatment of neonatal and juvenile diseases; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea; An immunotherapeutic agent for the treatment of cattle and other ruminants, namely, for the treatment of diarrhea in neonates
Pseudo MarkAMPLIFIED IMMUNE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 11, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavive Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N4Z7
CA
Party NameNovavive Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N4Z7
CA
Party NameNovavive Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBelleville, Ontario K8N4Z7
CA

Trademark Events

Event DateEvent Description
Monday, May 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 12, 2015NOTICE OF PSEUDO MARK E-MAILED
Monday, August 10, 2015ASSIGNED TO EXAMINER
Wednesday, August 12, 2015SUSPENSION LETTER WRITTEN
Wednesday, August 12, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, August 12, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 12, 2016SUSPENSION INQUIRY WRITTEN
Friday, February 12, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, February 12, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, August 3, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 12, 2016ASSIGNED TO LIE
Monday, August 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 19, 2016SUSPENSION LETTER WRITTEN
Friday, August 19, 2016LETTER OF SUSPENSION E-MAILED
Friday, August 19, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, November 15, 2016ASSIGNED TO EXAMINER
Friday, February 24, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, February 26, 2017SUSPENSION INQUIRY WRITTEN
Sunday, February 26, 2017INQUIRY TO SUSPENSION E-MAILED
Sunday, February 26, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 17, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 28, 2017SUSPENSION LETTER WRITTEN
Monday, August 28, 2017LETTER OF SUSPENSION E-MAILED
Monday, August 28, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 20, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, October 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 3, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 23, 2018REGISTERED-PRINCIPAL REGISTER
Monday, January 23, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, January 11, 2024TEAS SECTION 8 & 15 RECEIVED
Thursday, July 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 8, 2024POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Thursday, August 29, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Friday, August 30, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 30, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

amplimune treatment immunotherapeutic ruminants namely agent diarrhea other cattle neonates neonatal